Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various bioph…
Biotechnology
US, New York [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Royalty Pharma plc's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2020 | - | 2.460 | - | 1,801 | - | 1,483 | - | 1,299 | - | 1,290 | - | 155 |
| 2021 | 1.3200 | 2.864 | 2,122 | 2,155 | 495 | 645 | 1,882 | 854 | 1,506 | 1,526 | 182 | 202 |
| 2022 | 1.1500 | 3.636 | 2,289 | 2,791 | 478 | 475 | 1,482 | 878 | 1,407 | 1,112 | 182 | 212 |
| 2023 | 0.0978 | 4.235 | 2,237 | 2,985 | 42 | 673 | 983 | 1,053 | 917 | 1,285 | 227 | 242 |
| 2024 | 2.5400 | 3.949 | 2,354 | 2,692 | 1,134 | 2,380 | 1,492 | 1,942 | 931 | 1,928 | 249 | 231 |
| 2025 | - | 4.326 | - | 2,941 | - | 2,626 | - | 2,122 | - | 2,106 | - | 253 |
| 2026 | - | 4.778 | - | 3,304 | - | 2.F6X/td> | - | 2.F61/td> | - | 2.F61 | - | 2.F61 |
| 2027 | - | 6.060 | - | 3,971 | - | 1.F7X/td> | - | 1.F71/td> | - | 1.F71 | - | 1.F71 |
| 2028 | - | 6.920 | - | 4,478 | - | 0.F8X/td> | - | 0.F81/td> | - | 0.F81 | - | 0.F81 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
Overweight
Prev. Grade
Overweight
Nov. 6, 2024
Overweight
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
-51.419% $13.59 · MISS
Nov. 6, 2024Price Then
$27.54
Price Target
$40.02
Price Now
$26.43